News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Abemaciclib Plus Fulvestrant in Advanced Breast Cancer
Kevin Kalinsky/winshipcancer.emory.edu
Jan 19, 2025, 07:17

Abemaciclib Plus Fulvestrant in Advanced Breast Cancer

Dana-Farber’s Breast Oncology Center posted on X, about recent paper by Kevin Kalinsky et al., titled “Abemaciclib Plus Fulvestrant in Advanced Breast Cancer Following Progression on CDK4/6 Inhibition: Results from the Phase III postMONARCH Trial“ published on Journal of Clinical Oncology.

Authors: Kevin Kalinsky, Giampaolo Bianchini, Erika Hamilton, Stephanie L. Graff, Kyong Hwa Park, Rinath Jeselsohn, Umut Demirci, Miguel Martin, Rachel M. Layman, Sara A. Hurvitz, Sarah Sammons, Peter A. Kaufman, Montserrat Muñoz, Jiun-I Lai, Holly Knoderer, Cynthia Sandoval, Aarti R. Chawla, Bastien Nguyen, Yanhong Zhou, Elizabeth Ravenberg, Lacey M. Litchfield, Lillian Smyth, Seth A. Wander.

Abemaciclib Plus Fulvestrant in Advanced Breast Cancer

“New at Journal of Clinical Oncology. Abemaciclib Plus Fulvestrant in Advanced Breast Cancer Following Progression on CDK4/6 Inhibition: Results from the Phase III postMONARCH Trial.“

Aarti R. Chawla Abemaciclib Bastien Nguyen Breast Cancer cancer Cynthia Sandoval Dana-Farber’s Breast Oncology Center Elizabeth Ravenberg Erika Hamilton Fulvestrant Giampaolo Bianchini Holly Knoderer Jiun-I Lai Journal of Clinical Oncology Kevin Kalinsky Kyong Hwa Park Lacey M. Litchfield Lillian Smyth Miguel Martin Montserrat Muñoz OncoDaily Oncology Peter A Kaufman postMONARCH Trial Rachel M. Layman Rinath Jeselsohn Sara A. Hurvitz Sarah Sammons Seth A Wander Stephanie L. Graff Umut Demirci Yanhong Zhou
Special Coverage
Insight
May 9, 2025, 13:01
Ahmed Alanazi: T-DXd Achieves Primary Endpoint in Early Breast Cancer Neoadjuvant Trial (DB-11)
Science
May 9, 2025, 12:49
The Evolving Therapeutic Revolution in Adult Acute Lymphoblastic Leukemia
Drugs
May 9, 2025, 12:42
Penpulimab: What patients need to know?
Blog
May 9, 2025, 12:36
Avisek Banerjee: Proud to support Triparna Sen for 2025 IASLC Board of Directors (Basic Science) ballot
Science
May 9, 2025, 12:28
Aaron Goodman Highlights IL18-Secreting CAR T Therapy for Refractory Lymphoma
Blog
May 9, 2025, 12:26
Caryn Lerman: Join us for the 3rd Annual Cancer Research Day
Blog
May 9, 2025, 12:18
Navneet Singh: Overcoming Challenges and Embracing Novel Technologies in Lung Cancer Screening
Blog
May 9, 2025, 12:14
Aakash Desai Highlights New Study on BRAF-Mutated NSCLC: Personalization Over One-Size-Fits-All
History
May 9, 2025, 11:55
Celebrating AACR's Founding Anniversary - From 11 Prominent Scientists to 59,000 Research Leaders
Blog
May 9, 2025, 11:53
Amol Akhade Discusses POTOMAC Phase 3 Results in High-Risk NMIBC
Blog
May 9, 2025, 11:53
Dato’ Dr Saunthari Somasundaram Elected as Visionary President-Elect of the NCD Alliance (2025–2027)
Blog
May 9, 2025, 11:53
Robert Ferris Highlights Breakthrough Ewing Sarcoma Drug Discovery from UNC Lineberger